Evidence map›Paper›PMID 12853389›Full record

ArticleClinical and diagnostic laboratory immunology2003

Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.

C Yu, R E Engle, J P Bryan, S U Emerson, R H Purcell

Open access · diamondAbstract read
In one paragraph

Article in Clinical and diagnostic laboratory immunology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. [Laboratory diagnosis of hepatitis type E].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
  3. Laboratory Diagnosis of HEV Infection.Advances in experimental medicine and biology · 2023
    Review
  4. Immunobiology and Host Response to HEV.Advances in experimental medicine and biology · 2023
    Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Autochthonous hepatitis e virus infections: a new transfusion-associated risk?Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2014
    Review
  14. Diagnosis of hepatitis E.Nature reviews. Gastroenterology & hepatology · 2013
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

C YuHepatitis Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20852, USA. clyu@niaid.nih.gov
R E Engle
J P Bryan
S U Emerson
R H Purcell
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USUniformed Services University of the Health Sciences · US

Funding

In Vivo And In Vitro Studies Of Hepatitis E VirusZIAAI000596 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI EMERSON, SUZANNE U · 2009 to 2014
$3.4M
Search For New and Emerging Etiologic AgentsZIAAI000311 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI PURCELL, ROBERT H. · 2009 to 2013
$3.2M
SEARCH FOR NEW HEPATITIS AGENTSZ01AI000311 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI PURCELL, ROBERT H. · 1985 to 2008
$1.7M
IN VIVO AND IN VITRO STUDIES OF HEPATITIS E VIRUSZ01AI000596 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI EMERSON, SUZANNE · 1992 to 2008
$1.3M
6 · The paper itself

Abstract

The measurement of antibodies to hepatitis E virus (anti-HEV) has been essential for understanding the epidemiology of hepatitis E. Studies to determine the prevalence of HEV infections require a reliable serologic assay that is sensitive and specific. It is also important to distinguish the acute from the convalescent phase of an infection; this usually requires the detection of the immunoglobulin M (IgM) class of antibody. Few enzyme immunoassays (EIAs) that measure IgM anti-HEV have been described, and most have utilized the sandwich method. The present study describes an EIA that detects IgM anti-HEV by antibody class capture methodology. The assay was validated by using serum and/or plasma panels from experimentally infected nonhuman primates. It was used to demonstrate an anamnestic response and the reappearance of IgM anti-HEV in a chimpanzee experimentally challenged with HEV at two different times 45 months apart. The class capture method was more sensitive than the sandwich EIA when used to test clinical samples from two hepatitis E epidemics in Pakistan; it also had the advantage of distinguishing IgM anti-HEV in the presence of high titers of IgG anti-HEV.

Indexed as

AnimalsDisease OutbreaksHepatitis AntibodiesHepatitis AntigensHepatitis EHepatitis E virusHumansImmunoenzyme TechniquesImmunoglobulin GImmunoglobulin MPakistanPan troglodytesRecombinant Fusion ProteinsViral ProteinsHepatitis AntibodiesHepatitis AntigensImmunoglobulin GImmunoglobulin MORF2 protein, Hepatitis E virusRecombinant Fusion ProteinsViral Proteins

Identifiers

PMID12853389
PMCPMC164280
OpenAlexW2137569799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.